Hinge Health, Inc. (HNGE) Tops Q4 EPS by 35c, provides guidance
Hinge Health, Inc. (NYSE: HNGE) reported Q4 EPS of $0.49, $0.35 better than the analyst estimate of $0.14. Revenue for the quarter came in at $170.7 million.
GUIDANCE:
Hinge Health, Inc. sees Q1 2026 revenue of $171-173 million, versus the consensus of $159.7 million.

Hinge Health, Inc. sees FY2026 revenue of $732-742 million, versus the consensus of $700.4 million.
For earnings history and earnings-related data on Hinge Health, Inc. (HNGE) click here.

